Breaks Categories: Stock Spotlights

FridayNov 30, 2018 3:15 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Strengthens Senior Management Team

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development (“R&D”) company, recently fortified its marketing and compliance efforts with the appointment of new senior management members. A recent article discussing the company reads, “TGOD further strengthened its senior management team with two new appointments: Emily Demeo as its marketing brand director and Terry Reid as its director, legal and compliance. Demeo has joined from Molson Coors Canada (MCC), where she led MCC’s foray into non-alcoholic beverages, gaining valuable marketing experience in a regulated industry. Before her stint at MCC, Demeo worked at L’Oreal as senior…

Continue Reading

FridayNov 30, 2018 2:26 pm

CannabisNewsBreaks – Why Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is “One to Watch”

Supreme Cannabis Company (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) the sole Canadian licensed cannabis producer principally focused on premium brands and products with coast-to-coast distribution. A recent article further discussing the company reads, “Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.” … Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the…

Continue Reading

ThursdayNov 29, 2018 11:14 am

CannabisNewsBreaks – Why Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is “One to Watch”

Sproutly Canada (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is engaged in developing and bringing to market cannabis consumer products with a focus on beverages. A recent article discussing the company reads, “Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined…

Continue Reading

WednesdayNov 21, 2018 12:42 pm

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Holds a Unique Advantage Over its Competitors

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, anticipates that construction of its state-of-the-art indoor growing facilities will be completed in early 2019. Completion of the facilities, which will initially total 85,000 square feet, could give the company an advantage over its competition. An article further discussing the company reads, “In the cannabis sector, Flowr could become one of the most sought-after companies by investors, according to a recent report by Clarus Securities analyst Noel Atkinson. Atkinson rated the stock a “Speculative Buy,” as he believes Flowr has a unique advantage in that it will be able…

Continue Reading

TuesdayNov 20, 2018 2:49 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Raises $1.5M in Private Placement to Fund Canadian Lab

British Columbia, Canada-based Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is a biotechnology company and developer of technology which has demonstrated faster and more effective delivery of cannabinoids and nicotine. Recently, LXRP raised funds through a non-brokered private placement that it intends to use toward the construction of a new Canadian lab, research & development and general corporate purposes. A recent article discussing the company reads, “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has raised, in a non-brokered private placement, a total of $1,515,440. Net proceeds will be used for construction of a new lab in Canada, LXRP-driven R&D and general…

Continue Reading

TuesdayNov 20, 2018 12:17 pm

CannabisNewsBreaks – Why Plus Products Inc. (CSE: PLUS) is “One to Watch”

Plus Products (CSE: PLUS) is a branded cannabis-infused products manufacturer headquartered in San Mateo, California. The company focusses on creating edibles using extracts to ensure compliant, consistent products. A recent article discussing the company reads, “Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up…

Continue Reading

FridayNov 16, 2018 2:54 pm

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Targets Canadian Medical and Recreational Markets

Vertically integrated Canadian cannabis company The Flowr Corporation (TSX.V: FLWR) obtained its sales license from Health Canada in August of this year, thereby permitting FLWR to sell to both the medical and the adult-use recreational markets. An article discussing the company reads, “The Flowr Corporation is headquartered in Markham, Ontario, and has production facilities in Kelowna, BC.  It is constructing a flagship 85,000 square foot cultivation facility using proprietary growing systems and designs and engineered meet pharmaceutical quality production standards. It is currently operational at approximately 20 percent, with the remaining 80 percent scheduled to come online early in 2019. …

Continue Reading

WednesdayNov 07, 2018 1:50 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Continues to Grow International IP Portfolio

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is unwavering in its commitment to build its strategic intellectual property (“IP”) portfolio. Recently, LXRP was granted two new U.S. patents regarding cannabinoid-infused beverage compositions using its DehydraTECH ingestion technology platform. A recent article discussing the company reads, “LXRP has now filed a total of more than 50 patent applications across 10 current patent families. It is preparing applications for at least six more patents that will each form the basis for a separate patent family. It expects to file them before the end of this year, giving it management over a total of…

Continue Reading

TuesdayNov 06, 2018 2:47 pm

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Racks Up Achievements During October

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, aims to be the top supplier of premium, non-irradiated cannabis to the Canadian medicinal and recreational-use markets. An article discussing the FLWR’s recent achievements reads: “The Company, which began trading on the TSX Venture Exchange in late September, bucked industry trends by completely filling its purchase orders from three provinces before adult use legalization, launched a new cannabis brand in partnership with the team from Ace Hill Beer, broke ground on its first-of-its-kind R&D facility, and kicked off its medical sales program. … Throughout early October, Flowr announced it…

Continue Reading

TuesdayNov 06, 2018 1:11 pm

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Sees Promising Future Following the Removal of CBD from Schedule 1 List of Controlled Substances

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a hemp-cultivated cannabinoid innovator, applauded the recent elimination of cannabidiol (“CBD”) from the DEA’s Schedule 1 list of controlled substances. A recent article discussing the company reads, “Recently, Phivida Holdings talked about the removal of cannabidiol (CBD) from the U.S. Drug Enforcement Administration’s Schedule 1 list of controlled substances. In a news release, Jim Bailey, president and chief executive officer of Phivida, said, ‘We see this reclassification of CBD in pharmaceuticals as a good sign that will bolster the growing awareness of CBD as a substance that delivers many benefits, and opens the door…

Continue Reading